Full-Time

Scientist – Biologics Analytical Development and Attribute Sciences

Posted on 11/19/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Entry

Summit, NJ, USA

On-site presence is required; occasional travel to BMS New Brunswick, New Jersey site expected.

Category
Bioinformatics
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • A PhD/Doctorate degree in Analytical Biochemistry, Analytical Chemistry, Biotechnology, or related field with 0 to 2 years of relevant industry and/or academic experience, or a Masters degree and 2 to 4 years of relevant experience, or Bachelors degree and 5 to 7 years of relevant experience.
  • Excellent communication and organizational skills, supported by a strong record of publications and presentations.
  • The ability to work collaboratively in a team environment is essential.
  • Experience in a variety of protein analytical techniques, which may include affinity LC, N-glycan characterization, iCIEF, size exclusion HPLC and UPLC, capillary electrophoresis, ELISA, and mass spectrometry.
  • Experience with sample preparation techniques a plus including affinity purification and other SPE approaches.
  • Experience in programming and usage of robotic liquid handlers, such as Tecan, Hamilton or similar platforms, is beneficial.
  • Knowledge and experience of nucleotide bioanalytical techniques is useful, including southern blot, northern blot, reverse transcription, and qPCR.
  • Skill in utilizing scientific computer software is beneficial, including Empower, LIMS software, SYMYX ELN, JMP, Microsoft office applications.
Responsibilities
  • Support analytical testing for monoclonal antibodies and fusion proteins, including HPLC/UPLC, isoelectric focusing, capillary electrophoresis, ELISA, qPCR, etc. Mass Spectrometry experience is beneficial.
  • Implement state-of-the-art lab automation to simplify and streamline lab work (Tecan, Andrew+, others)
  • Evaluate new analytical methods for improving analytical capability and assay performance.
  • Support method standardization activities in collaboration with partner groups at New Brunswick NJ, Devens MA, and other BMS sites.
  • Authoring technical reports, methods, and/or regulatory submissions to support our pipeline.
  • Collaborate closely with Research and Development, Characterization, Manufacturing Process Development, and Clinical Manufacturing teams.
  • Maintain accurate and up to date laboratory e-notebook documentation.
  • Learn analytical skills needed to support future assays for the next generation of biologics programs.
  • On-site presence is required to complete the primary responsibilities of this position. Occasional travel to the BMS New Brunswick, New Jersey site is expected.
  • This role requires office work, chemical laboratory work, computer work, group meetings, and thus involves the ability to work at a laboratory bench and in fume hoods, working with analytical instruments, repetitive motion including bending and lifting small containers/equipment.
  • Sustain a safe and high-performance laboratory environment. This is essential as the candidate will be working with potentially hazardous materials (corrosives, flammable solvents, toxic or potent compounds).

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's collaboration with Prime Medicine enhances its cell and gene-therapy pipeline.
  • The rise of digital health technologies boosts BMS's R&D efficiency.
  • BMS's focus on biosimilars opens new market opportunities globally.

What critics are saying

  • BMS faces a $6.4 billion lawsuit over Celgene drug approval delays.
  • The 340B Drug Pricing Program lawsuit could lead to regulatory challenges.
  • High financial stakes in the Prime Medicine agreement pose development risks.

What makes Bristol-Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases for innovative treatments.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE